| skeletal system development | GO:0001501 | 356 | 0.293 | |
| appendage development | GO:0048736 | 166 | 0.278 | |
| kidney development | GO:0001822 | 213 | 0.264 | |
| muscle tissue development | GO:0060537 | 308 | 0.246 | |
| regionalization | GO:0003002 | 337 | 0.226 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.225 | |
| limb development | GO:0060173 | 166 | 0.183 | |
| renal system development | GO:0072001 | 225 | 0.177 | |
| respiratory tube development | GO:0030323 | 167 | 0.169 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.166 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.159 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.158 | |
| male gamete generation | GO:0048232 | 285 | 0.158 | |
| urogenital system development | GO:0001655 | 261 | 0.139 | |
| forebrain development | GO:0030900 | 302 | 0.134 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.131 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.130 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.124 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.119 | |
| spleen development | GO:0048536 | 39 | 0.118 | |
| spermatogenesis | GO:0007283 | 284 | 0.115 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.115 | |
| embryonic skeletal system morphogenesis | GO:0048704 | 91 | 0.112 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.112 | |
| germ cell development | GO:0007281 | 185 | 0.108 | |
| axis elongation involved in somitogenesis | GO:0090245 | 4 | 0.106 | |
| protein autoprocessing | GO:0016540 | 2 | 0.101 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.100 | |
| regulation of sphingolipid mediated signaling pathway | GO:1902068 | 2 | 0.097 | |
| negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090101 | 61 | 0.096 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.096 | |
| embryonic skeletal system development | GO:0048706 | 120 | 0.095 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.094 | |
| circulatory system process | GO:0003013 | 197 | 0.094 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.092 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.089 | |
| amine metabolic process | GO:0009308 | 45 | 0.088 | |
| erythrocyte differentiation | GO:0030218 | 88 | 0.085 | |
| telencephalon development | GO:0021537 | 186 | 0.085 | |
| mapk cascade | GO:0000165 | 281 | 0.081 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.081 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.079 | |
| muscle system process | GO:0003012 | 141 | 0.078 | |
| wnt signaling pathway involved in forebrain neuroblast division | GO:0021874 | 2 | 0.076 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.075 | |
| lung alveolus development | GO:0048286 | 45 | 0.075 | |
| cation transport | GO:0006812 | 399 | 0.074 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.074 | |
| cytokine biosynthetic process | GO:0042089 | 68 | 0.071 | |
| embryonic limb morphogenesis | GO:0030326 | 126 | 0.071 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.070 | |
| response to radiation | GO:0009314 | 165 | 0.070 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.070 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.069 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.068 | |
| zygotic determination of anterior posterior axis embryo | GO:0007354 | 3 | 0.068 | |
| negative regulation of cholesterol transport | GO:0032375 | 4 | 0.067 | |
| trachea cartilage morphogenesis | GO:0060535 | 4 | 0.067 | |
| cytokine metabolic process | GO:0042107 | 71 | 0.067 | |
| protein processing | GO:0016485 | 163 | 0.066 | |
| limb morphogenesis | GO:0035108 | 149 | 0.065 | |
| regulation of cell activation | GO:0050865 | 289 | 0.065 | |
| skin development | GO:0043588 | 220 | 0.065 | |
| planar cell polarity pathway involved in pericardium morphogenesis | GO:0061354 | 2 | 0.065 | |
| response to oxygen levels | GO:0070482 | 62 | 0.065 | |
| ear morphogenesis | GO:0042471 | 118 | 0.064 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.063 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.063 | |
| mesonephros development | GO:0001823 | 97 | 0.062 | |
| epidermis development | GO:0008544 | 187 | 0.061 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.061 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.060 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.060 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.060 | |
| nuclear division | GO:0000280 | 158 | 0.060 | |
| epithelial cell morphogenesis | GO:0003382 | 41 | 0.059 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.059 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.058 | |
| regulation of circadian sleep wake cycle sleep | GO:0045187 | 3 | 0.058 | |
| regulation of bmp signaling pathway | GO:0030510 | 60 | 0.058 | |
| ear development | GO:0043583 | 200 | 0.058 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.058 | |
| mesonephric tubule development | GO:0072164 | 94 | 0.057 | |
| single fertilization | GO:0007338 | 82 | 0.056 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.055 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.055 | |
| binding of sperm to zona pellucida | GO:0007339 | 34 | 0.054 | |
| embryonic appendage morphogenesis | GO:0035113 | 126 | 0.054 | |
| skeletal muscle fiber development | GO:0048741 | 58 | 0.053 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.053 | |
| planar cell polarity pathway involved in cardiac muscle tissue morphogenesis | GO:0061350 | 2 | 0.053 | |
| leukocyte apoptotic process | GO:0071887 | 71 | 0.052 | |
| locomotory behavior | GO:0007626 | 195 | 0.052 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.052 | |
| regulation of cyclic nucleotide metabolic process | GO:0030799 | 40 | 0.051 | |
| fertilization | GO:0009566 | 127 | 0.051 | |
| sensory perception of mechanical stimulus | GO:0050954 | 107 | 0.051 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.050 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.050 | |
| regulation of gtp catabolic process | GO:0033124 | 113 | 0.050 | |
| negative regulation of mesenchymal cell proliferation | GO:0072201 | 3 | 0.050 | |
| regulation of circadian sleep wake cycle | GO:0042749 | 3 | 0.050 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.049 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.049 | |
| gland development | GO:0048732 | 330 | 0.049 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.049 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.049 | |
| neural tube closure | GO:0001843 | 90 | 0.048 | |
| axonogenesis | GO:0007409 | 274 | 0.048 | |
| platelet derived growth factor receptor alpha signaling pathway | GO:0035790 | 3 | 0.048 | |
| tube closure | GO:0060606 | 91 | 0.048 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.047 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.047 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.047 | |
| cell cell recognition | GO:0009988 | 44 | 0.047 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.047 | |
| sensory perception | GO:0007600 | 245 | 0.045 | |
| skeletal muscle cell differentiation | GO:0035914 | 66 | 0.045 | |
| respiratory system development | GO:0060541 | 190 | 0.045 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.045 | |
| renal tubule development | GO:0061326 | 87 | 0.045 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.045 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.045 | |
| t cell differentiation | GO:0030217 | 174 | 0.044 | |
| ossification | GO:0001503 | 216 | 0.044 | Human |
| response to oxidative stress | GO:0006979 | 123 | 0.044 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.043 | |
| kidney epithelium development | GO:0072073 | 121 | 0.043 | |
| protein maturation | GO:0051604 | 176 | 0.042 | |
| regulation of macrophage activation | GO:0043030 | 17 | 0.042 | |
| positive regulation of ras gtpase activity | GO:0032320 | 65 | 0.042 | |
| ventricular septum development | GO:0003281 | 42 | 0.041 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.041 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.041 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.041 | Human |
| inner ear morphogenesis | GO:0042472 | 101 | 0.041 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.040 | |
| oxidation reduction process | GO:0055114 | 342 | 0.040 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.040 | |
| smooth muscle contraction | GO:0006939 | 44 | 0.040 | |
| kidney morphogenesis | GO:0060993 | 83 | 0.040 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.040 | |
| endothelium development | GO:0003158 | 45 | 0.040 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.040 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.040 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.040 | |
| planar cell polarity pathway involved in ventricular septum morphogenesis | GO:0061348 | 2 | 0.039 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.039 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.039 | |
| response to peptide | GO:1901652 | 136 | 0.038 | |
| central nervous system morphogenesis | GO:0021551 | 2 | 0.038 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.038 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.038 | |
| cytokine production | GO:0001816 | 319 | 0.038 | Mouse |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.037 | |
| smoothened signaling pathway | GO:0007224 | 105 | 0.037 | |
| lung epithelium development | GO:0060428 | 37 | 0.037 | |
| negative regulation of prostatic bud formation | GO:0060686 | 4 | 0.037 | |
| primary neural tube formation | GO:0014020 | 95 | 0.037 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.037 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.037 | |
| cofactor metabolic process | GO:0051186 | 80 | 0.037 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.037 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.036 | |
| mammary placode formation | GO:0060596 | 4 | 0.036 | |
| synaptic transmission | GO:0007268 | 329 | 0.036 | |
| regulation of protein processing | GO:0070613 | 96 | 0.036 | |
| nephric duct formation | GO:0072179 | 4 | 0.036 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.036 | |
| oviduct development | GO:0060066 | 3 | 0.036 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.036 | |
| nucleoside phosphate biosynthetic process | GO:1901293 | 79 | 0.035 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.035 | |
| embryonic digestive tract development | GO:0048566 | 27 | 0.035 | |
| mesonephric epithelium development | GO:0072163 | 94 | 0.035 | |
| endocytosis | GO:0006897 | 168 | 0.035 | |
| cellular homeostasis | GO:0019725 | 240 | 0.035 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.035 | |
| cyclic nucleotide metabolic process | GO:0009187 | 59 | 0.035 | |
| negative regulation of hormone biosynthetic process | GO:0032353 | 4 | 0.035 | |
| inflammatory response | GO:0006954 | 244 | 0.035 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.035 | |
| planar cell polarity pathway involved in cardiac right atrium morphogenesis | GO:0061349 | 2 | 0.035 | |
| ureteric bud development | GO:0001657 | 94 | 0.035 | |
| cell differentiation in hindbrain | GO:0021533 | 24 | 0.034 | |
| interleukin 8 production | GO:0032637 | 4 | 0.034 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.034 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.034 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.034 | |
| lipid transport | GO:0006869 | 98 | 0.034 | |
| planar cell polarity pathway involved in outflow tract morphogenesis | GO:0061347 | 2 | 0.033 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.033 | |
| t cell proliferation | GO:0042098 | 120 | 0.033 | Mouse |
| activation of mapk activity | GO:0000187 | 59 | 0.033 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.033 | |
| spermatid differentiation | GO:0048515 | 115 | 0.033 | |
| protein ubiquitination | GO:0016567 | 171 | 0.032 | |
| branching involved in ureteric bud morphogenesis | GO:0001658 | 56 | 0.032 | |
| spinal cord development | GO:0021510 | 81 | 0.032 | |
| mesonephric duct morphogenesis | GO:0072180 | 4 | 0.032 | |
| regulation of mesenchymal cell proliferation | GO:0010464 | 37 | 0.032 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.032 | |
| tertiary branching involved in mammary gland duct morphogenesis | GO:0060748 | 3 | 0.032 | |
| midgut development | GO:0007494 | 4 | 0.032 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.032 | |
| hormone metabolic process | GO:0042445 | 86 | 0.032 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.032 | |
| multicellular organism growth | GO:0035264 | 161 | 0.032 | |
| regulation of kidney development | GO:0090183 | 40 | 0.032 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.032 | |
| muscle contraction | GO:0006936 | 101 | 0.031 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.031 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.031 | |
| neural tube development | GO:0021915 | 160 | 0.031 | |
| positive regulation of interleukin 8 secretion | GO:2000484 | 1 | 0.031 | |
| cell maturation | GO:0048469 | 127 | 0.031 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.031 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.031 | |
| negative regulation of peptidase activity | GO:0010466 | 46 | 0.031 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.031 | |
| positive regulation of dna templated transcription elongation | GO:0032786 | 2 | 0.031 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.031 | |
| organic anion transport | GO:0015711 | 137 | 0.031 | |
| positive regulation of organ growth | GO:0046622 | 29 | 0.030 | |
| extracellular structure organization | GO:0043062 | 148 | 0.030 | |
| maintenance of location | GO:0051235 | 89 | 0.030 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.030 | |
| hemostasis | GO:0007599 | 78 | 0.030 | |
| regulation of cardiac muscle tissue development | GO:0055024 | 31 | 0.030 | |
| determination of left right symmetry | GO:0007368 | 80 | 0.030 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.030 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.030 | |
| purine ribonucleotide biosynthetic process | GO:0009152 | 59 | 0.030 | |
| hair cycle | GO:0042633 | 90 | 0.030 | |
| fat cell differentiation | GO:0045444 | 160 | 0.030 | Human |
| organophosphate catabolic process | GO:0046434 | 232 | 0.030 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.030 | |
| cervix development | GO:0060067 | 2 | 0.030 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.030 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.030 | |
| gas homeostasis | GO:0033483 | 3 | 0.030 | |
| fibroblast growth factor receptor signaling pathway | GO:0008543 | 46 | 0.029 | |
| defense response to other organism | GO:0098542 | 197 | 0.029 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.029 | |
| generation of precursor metabolites and energy | GO:0006091 | 103 | 0.029 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.029 | |
| developmental induction | GO:0031128 | 34 | 0.029 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.029 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.029 | |
| coagulation | GO:0050817 | 78 | 0.029 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.029 | Mouse |
| regulation of t cell activation | GO:0050863 | 170 | 0.029 | |
| regulation of protein localization | GO:0032880 | 231 | 0.029 | |
| muscle tissue morphogenesis | GO:0060415 | 53 | 0.028 | |
| motor neuron migration | GO:0097475 | 4 | 0.028 | |
| camp biosynthetic process | GO:0006171 | 31 | 0.028 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.028 | |
| negative regulation of ossification | GO:0030279 | 49 | 0.028 | |
| sperm egg recognition | GO:0035036 | 37 | 0.028 | |
| regulation of nucleotide catabolic process | GO:0030811 | 122 | 0.027 | |
| negative regulation of bmp signaling pathway | GO:0030514 | 35 | 0.027 | |
| purine nucleotide biosynthetic process | GO:0006164 | 65 | 0.027 | |
| ureteric bud morphogenesis | GO:0060675 | 62 | 0.027 | |
| positive regulation of immature t cell proliferation | GO:0033091 | 4 | 0.027 | |
| cellular response to lipid | GO:0071396 | 145 | 0.027 | |
| peptide hormone processing | GO:0016486 | 9 | 0.027 | |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.027 | |
| heart morphogenesis | GO:0003007 | 178 | 0.027 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.027 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.027 | |
| positive regulation of transcription elongation from rna polymerase ii promoter | GO:0032968 | 2 | 0.027 | |
| regulation of fat cell proliferation | GO:0070344 | 4 | 0.027 | |
| organelle fission | GO:0048285 | 170 | 0.027 | |
| specification of organ identity | GO:0010092 | 30 | 0.027 | |
| membrane organization | GO:0061024 | 245 | 0.027 | |
| regulation of interleukin 8 secretion | GO:2000482 | 2 | 0.026 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.026 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.026 | |
| lung development | GO:0030324 | 164 | 0.026 | |
| myoblast differentiation involved in skeletal muscle regeneration | GO:0014835 | 3 | 0.026 | |
| compound eye development | GO:0048749 | 1 | 0.026 | |
| cardiac muscle cell differentiation | GO:0055007 | 69 | 0.026 | |
| negative regulation of hydrolase activity | GO:0051346 | 71 | 0.026 | |
| forelimb morphogenesis | GO:0035136 | 40 | 0.026 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.026 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.026 | |
| energy derivation by oxidation of organic compounds | GO:0015980 | 77 | 0.026 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.026 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.026 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.025 | |
| cell matrix adhesion | GO:0007160 | 68 | 0.025 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.025 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.025 | |
| determination of heart left right asymmetry | GO:0061371 | 48 | 0.025 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.025 | |
| l glutamate import into cell | GO:1990123 | 3 | 0.025 | |
| hindbrain morphogenesis | GO:0021575 | 46 | 0.025 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.025 | |
| cell growth | GO:0016049 | 130 | 0.025 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.025 | |
| renal vesicle induction | GO:0072034 | 3 | 0.025 | |
| response to acid chemical | GO:0001101 | 111 | 0.025 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.025 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.025 | |
| negative regulation of canonical wnt signaling pathway | GO:0090090 | 51 | 0.025 | |
| regulation of lymphocyte apoptotic process | GO:0070228 | 41 | 0.025 | |
| cell migration involved in gastrulation | GO:0042074 | 13 | 0.024 | |
| regulation of chondrocyte differentiation | GO:0032330 | 33 | 0.024 | Human |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.024 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.024 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.024 | |
| negative regulation of cellular catabolic process | GO:0031330 | 47 | 0.024 | |
| platelet aggregation | GO:0070527 | 20 | 0.024 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.024 | |
| embryonic digit morphogenesis | GO:0042733 | 56 | 0.024 | |
| regulation of non canonical wnt signaling pathway | GO:2000050 | 12 | 0.024 | |
| lobar bronchus development | GO:0060482 | 6 | 0.024 | |
| mitotic chromosome condensation | GO:0007076 | 1 | 0.024 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.024 | |
| regulation of erythrocyte differentiation | GO:0045646 | 23 | 0.024 | |
| pancreas development | GO:0031016 | 57 | 0.024 | |
| organic acid transport | GO:0015849 | 101 | 0.023 | |
| regulation of cell motility | GO:2000145 | 236 | 0.023 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.023 | |
| endothelial cell morphogenesis | GO:0001886 | 9 | 0.023 | |
| cytokine mediated signaling pathway | GO:0019221 | 115 | 0.023 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.023 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.023 | |
| endodermal cell fate specification | GO:0001714 | 4 | 0.023 | |
| negative regulation of protein maturation | GO:1903318 | 79 | 0.023 | |
| mesenchyme development | GO:0060485 | 152 | 0.023 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.023 | |
| uterus morphogenesis | GO:0061038 | 2 | 0.023 | |
| positive regulation of epithelial cell proliferation involved in lung morphogenesis | GO:0060501 | 3 | 0.023 | |
| cartilage development | GO:0051216 | 140 | 0.023 | Human |
| regulation of metal ion transport | GO:0010959 | 106 | 0.023 | |
| interleukin 8 secretion | GO:0072606 | 3 | 0.023 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.023 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.023 | |
| nephron development | GO:0072006 | 109 | 0.023 | |
| nephron epithelium development | GO:0072009 | 92 | 0.023 | |
| sulfur compound metabolic process | GO:0006790 | 100 | 0.023 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.023 | |
| mesenchymal cell proliferation involved in ureter development | GO:0072198 | 4 | 0.023 | |
| axis elongation | GO:0003401 | 30 | 0.022 | |
| cerebellar granule cell precursor proliferation | GO:0021930 | 10 | 0.022 | |
| cerebellar cortex morphogenesis | GO:0021696 | 32 | 0.022 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.022 | |
| diencephalon development | GO:0021536 | 63 | 0.022 | |
| response to steroid hormone | GO:0048545 | 56 | 0.022 | |
| enkephalin processing | GO:0034230 | 1 | 0.022 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.022 | |
| lateral line system development | GO:0048925 | 1 | 0.022 | |
| development of primary male sexual characteristics | GO:0046546 | 88 | 0.022 | |
| heart process | GO:0003015 | 94 | 0.022 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.022 | |
| negative regulation of hormone metabolic process | GO:0032351 | 4 | 0.022 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.022 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.022 | |
| non canonical wnt signaling pathway involved in heart development | GO:0061341 | 3 | 0.022 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.022 | |
| embryonic placenta development | GO:0001892 | 98 | 0.021 | |
| mesonephric tubule morphogenesis | GO:0072171 | 63 | 0.021 | |
| cardiac septum development | GO:0003279 | 59 | 0.021 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 129 | 0.021 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.021 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.021 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.021 | |
| cell recognition | GO:0008037 | 83 | 0.021 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.021 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.021 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.021 | |
| methylation | GO:0032259 | 134 | 0.021 | |
| response to decreased oxygen levels | GO:0036293 | 59 | 0.021 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 143 | 0.021 | |
| positive regulation of hormone secretion | GO:0046887 | 38 | 0.021 | |
| cellular response to oxidative stress | GO:0034599 | 76 | 0.021 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.021 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.021 | |
| purine containing compound biosynthetic process | GO:0072522 | 70 | 0.021 | |
| peptide metabolic process | GO:0006518 | 46 | 0.021 | |
| establishment of anatomical structure orientation | GO:0048560 | 1 | 0.021 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.021 | |
| amino acid import into cell | GO:1902837 | 4 | 0.021 | |
| negative regulation of cardiac chamber morphogenesis | GO:1901220 | 2 | 0.021 | |
| cholesterol metabolic process | GO:0008203 | 56 | 0.021 | |
| carboxylic acid transport | GO:0046942 | 100 | 0.021 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.021 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.021 | |
| developmental maturation | GO:0021700 | 193 | 0.021 | |
| rhythmic process | GO:0048511 | 174 | 0.020 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.020 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.020 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 122 | 0.020 | |
| regulation of defense response | GO:0031347 | 233 | 0.020 | |
| cellular response to arsenic containing substance | GO:0071243 | 4 | 0.020 | |
| positive regulation of purine nucleotide catabolic process | GO:0033123 | 88 | 0.020 | |
| cardiac septum morphogenesis | GO:0060411 | 46 | 0.020 | |
| calcium ion transport | GO:0006816 | 159 | 0.020 | |
| sterol metabolic process | GO:0016125 | 58 | 0.020 | |
| planar cell polarity pathway involved in heart morphogenesis | GO:0061346 | 3 | 0.020 | |
| negative regulation of cell projection organization | GO:0031345 | 56 | 0.020 | |
| cardiac muscle tissue morphogenesis | GO:0055008 | 44 | 0.020 | |
| lung morphogenesis | GO:0060425 | 50 | 0.020 | |
| metanephric loop of henle development | GO:0072236 | 4 | 0.020 | |
| maintenance of cell number | GO:0098727 | 3 | 0.020 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 133 | 0.020 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.020 | |
| somatic stem cell maintenance | GO:0035019 | 47 | 0.020 | |
| t cell apoptotic process | GO:0070231 | 39 | 0.020 | |
| blood circulation | GO:0008015 | 195 | 0.020 | |
| regulation of neural precursor cell proliferation | GO:2000177 | 70 | 0.020 | |
| endodermal cell fate determination | GO:0007493 | 2 | 0.020 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.020 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.020 | |
| positive regulation of transcription from rna polymerase ii promoter involved in heart development | GO:1901228 | 4 | 0.020 | |
| epithelial cell development | GO:0002064 | 159 | 0.020 | |
| odontogenesis of dentin containing tooth | GO:0042475 | 66 | 0.020 | |
| renal tubule morphogenesis | GO:0061333 | 72 | 0.020 | |
| neural tube patterning | GO:0021532 | 43 | 0.020 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.020 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.019 | |
| sensory system development | GO:0048880 | 3 | 0.019 | |
| negative regulation of response to wounding | GO:1903035 | 77 | 0.019 | |
| inner medullary collecting duct development | GO:0072061 | 2 | 0.019 | |
| response to fibroblast growth factor | GO:0071774 | 47 | 0.019 | |
| microtubule based process | GO:0007017 | 236 | 0.019 | |
| organ induction | GO:0001759 | 21 | 0.019 | |
| cardiac ventricle morphogenesis | GO:0003208 | 50 | 0.019 | |
| regulation of secretion | GO:0051046 | 274 | 0.019 | |
| cerebellum morphogenesis | GO:0021587 | 42 | 0.019 | |
| triglyceride metabolic process | GO:0006641 | 51 | 0.019 | |
| cellular response to metal ion | GO:0071248 | 31 | 0.019 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.019 | |
| nucleotide biosynthetic process | GO:0009165 | 78 | 0.019 | |
| negative regulation of epithelial cell proliferation | GO:0050680 | 64 | 0.019 | |
| retina morphogenesis in camera type eye | GO:0060042 | 45 | 0.019 | |
| response to inorganic substance | GO:0010035 | 96 | 0.019 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 88 | 0.019 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.019 | |
| nephron epithelium morphogenesis | GO:0072088 | 68 | 0.018 | |
| bone morphogenesis | GO:0060349 | 78 | 0.018 | |
| tube formation | GO:0035148 | 140 | 0.018 | |
| angiogenesis | GO:0001525 | 201 | 0.018 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 73 | 0.018 | |
| positive regulation of protein serine threonine kinase activity | GO:0071902 | 106 | 0.018 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.018 | |
| hepaticobiliary system development | GO:0061008 | 67 | 0.018 | |
| interspecies interaction between organisms | GO:0044419 | 83 | 0.018 | |
| anterior commissure morphogenesis | GO:0021960 | 6 | 0.018 | |
| male genitalia morphogenesis | GO:0048808 | 4 | 0.018 | |
| establishment of endothelial blood brain barrier | GO:0014045 | 3 | 0.018 | |
| cerebellum development | GO:0021549 | 77 | 0.018 | |
| uterus development | GO:0060065 | 16 | 0.018 | |
| developmental cell growth | GO:0048588 | 84 | 0.018 | |
| cyclic purine nucleotide metabolic process | GO:0052652 | 43 | 0.018 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.018 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 95 | 0.018 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.018 | |
| negative regulation of wnt signaling pathway involved in heart development | GO:0003308 | 4 | 0.018 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.018 | |
| cell proliferation in hindbrain | GO:0021534 | 10 | 0.018 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.018 | |
| positive regulation of transcription from rna polymerase ii promoter involved in myocardial precursor cell differentiation | GO:0003257 | 3 | 0.018 | |
| stress activated mapk cascade | GO:0051403 | 80 | 0.018 | |
| response to hypoxia | GO:0001666 | 58 | 0.018 | |
| positive regulation of peptide secretion | GO:0002793 | 33 | 0.018 | |
| positive regulation of chondrocyte differentiation | GO:0032332 | 13 | 0.018 | Human |
| cellular response to peptide hormone stimulus | GO:0071375 | 92 | 0.018 | |
| regulation of system process | GO:0044057 | 200 | 0.017 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.017 | |
| positive regulation of cyclic nucleotide metabolic process | GO:0030801 | 24 | 0.017 | |
| forebrain radial glial cell differentiation | GO:0021861 | 4 | 0.017 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.017 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.017 | |
| acylglycerol metabolic process | GO:0006639 | 55 | 0.017 | |
| metanephros development | GO:0001656 | 79 | 0.017 | |
| camp metabolic process | GO:0046058 | 40 | 0.017 | |
| negative regulation of cellular response to growth factor stimulus | GO:0090288 | 46 | 0.017 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.017 | |
| positive regulation of nucleoside metabolic process | GO:0045979 | 91 | 0.017 | |
